June 1, 2022 June 1, 2022Categories News StoriesPrecision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
May 17, 2022 May 17, 2022Categories Press ReleasesMedia Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio
April 11, 2022 April 11, 2022Categories News StoriesAs NCI-MATCH winds down, cancer research community takes stock of lessons learned
March 17, 2022 March 17, 2022Categories News StoriesNCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers
March 16, 2022 March 16, 2022Categories Press ReleasesPress Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations
March 1, 2022 March 1, 2022Categories News StoriesFDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts
April 26, 2021 April 26, 2021Categories Press ReleasesPress Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers
October 13, 2020 October 13, 2020Categories Press ReleasesPress Release: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks
